| Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732) |
|---|
| 06/05/2003 | US20030105072 Compounds, compositions, and methods for controlling biofilms |
| 06/04/2003 | EP1315709A1 Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 06/04/2003 | EP1105374B1 Lactam dehydration method |
| 06/04/2003 | EP0801647B1 Method of simultaneously preparing caprolactam and hexamethylene diamine |
| 06/04/2003 | CN1422253A Carbamate caspase inhibitors and uses thereof |
| 06/04/2003 | CN1422248A Process for the carbonylation of pentenenitrile |
| 06/04/2003 | CN1421474A Process for producing polycaprolactam |
| 06/04/2003 | CN1110482C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 05/29/2003 | US20030100755 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy |
| 05/28/2003 | EP1313426A4 Succinoylamino benzodiazepines as inhibitors of a-beta protein production |
| 05/28/2003 | EP1313426A2 Succinoylamino benzodiazepines as inhibitors of a-beta protein production |
| 05/27/2003 | CA2066104C Benzazepine derivatives as vasopressin antagonists |
| 05/22/2003 | WO2003042182A1 Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain |
| 05/22/2003 | WO2003042181A1 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivatives or salts thereof |
| 05/22/2003 | WO2002100327A3 Substituted 1-benzazepines and derivatives thereof |
| 05/22/2003 | WO2002026705A8 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and their preparation |
| 05/22/2003 | US20030096858 The parent drug compound is modified by forming one or more of predetermined chemical arrangement within parent drug structure for programming specific course and rate of metabolism for drug that leads to inactive nontoxic metabolite |
| 05/22/2003 | US20030095992 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/22/2003 | CA2464069A1 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof |
| 05/22/2003 | CA2463970A1 Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain |
| 05/21/2003 | CN1419540A Proces for the preparation of & epsii-caprolactam |
| 05/21/2003 | CN1418882A Substituted sulfonic N-[(amino imino methyl) phenyl alkyl]-acacycloamide compound |
| 05/21/2003 | CN1418809A Method for prepn. of high concentration hydroxymaline in the prodn. process of hexanolactam |
| 05/15/2003 | WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/15/2003 | CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/14/2003 | EP1310490A1 Gpr14 antagonist |
| 05/14/2003 | EP1309609A2 Lactam compounds and their use as inhibitors of serine proteases and method |
| 05/13/2003 | CA2115443C Azabicyclo arylacetylene and arylenyne oximes as cholinergic agents and methods of treatment |
| 05/08/2003 | WO2003037873A1 Substituted benzo[b]azepin-2-one compounds |
| 05/08/2003 | WO2003037271A2 Compounds, pharmaceutical compositions and methods of use therefor |
| 05/08/2003 | WO2002026750A8 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation |
| 05/08/2003 | US20030087901 Compounds and methods for modulation of estrogen receptors |
| 05/08/2003 | US20030087306 Methods for identifying novel multimeric agents that modulate receptors |
| 05/08/2003 | CA2464191A1 Substituted benzo[b]azepin-2-one compounds |
| 05/07/2003 | EP1308513A1 Use of polypeptide |
| 05/07/2003 | EP1307430A1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/07/2003 | EP1307426A1 Amino diphenyl ethers and amido diphenyl ethers |
| 05/07/2003 | EP1307204A1 Protease inhibitors |
| 05/07/2003 | EP1307203A1 Protease inhibitors |
| 05/07/2003 | EP0765314B1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 05/07/2003 | EP0709386B1 Fused benzazepine derivative and pharmaceutical composition containing the same |
| 05/07/2003 | CN1416418A Method for separation azepine derivative out of mixture contg. amine and azepine derivative |
| 05/07/2003 | CN1416346A Peotease inhibitors |
| 05/07/2003 | CN1415607A Method for synthesizing caprolactam |
| 05/07/2003 | CN1107648C Method for treating benzene extraction waste liquor in prodn. of caprolactam |
| 05/06/2003 | US6559141 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 05/02/2003 | EP1306371A1 Cyclic imines |
| 05/02/2003 | EP1306365A2 Cobalt supported catalysts for hydrogenation of nitriles |
| 05/02/2003 | EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 05/02/2003 | EP1305293A1 Hexahydro-7-imino-1h-azepin-2-yl-hexanoic acid derivatives as inhibitors of inducible nitric oxide synthase |
| 05/02/2003 | EP0988035B1 Caspases and apoptosis |
| 05/02/2003 | EP0738150B1 Bicyclic fibrinogen antagonists |
| 05/01/2003 | WO2003035599A1 Quarternary ammonium compounds and their use as antimuscarinic agents |
| 04/30/2003 | CN1107061C Chemotaxis cell factor receptor-3 receptor antagonists |
| 04/30/2003 | CN1107055C Method for preparation of lactan |
| 04/29/2003 | US6555580 Treating arteriosclerosis and hypercholesterolaemia |
| 04/29/2003 | US6555533 Specific antitumor activity against breast, colon, lung, prostate cancers and melanomas |
| 04/24/2003 | WO2003032910A2 Carbinols for the treatment of neuropathic dysfunction |
| 04/24/2003 | WO2003032908A2 Novel prodrugs of n-h bond-containing compounds and methods of making thereof |
| 04/24/2003 | WO2002098850A3 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 04/24/2003 | US20030078254 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 04/24/2003 | CA2463518A1 Carbinols for the treatment of neuropathic dysfunction |
| 04/24/2003 | CA2461557A1 Novel prodrugs of n-h bond-containing compounds and methods of making thereof |
| 04/23/2003 | CN1413191A Method for production of N-alkenyl amides |
| 04/22/2003 | US6552041 Cyclized amide derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 04/22/2003 | US6552017 Substituted heterocycle fused gamma-carbolines |
| 04/22/2003 | CA2211015C Method for preparing lactam |
| 04/16/2003 | EP1302464A1 Process for preparation of 10-methoxycarbamazepine |
| 04/16/2003 | EP1301482A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 04/16/2003 | EP0998451B1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 04/16/2003 | CN1411444A Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 04/16/2003 | CN1411443A Method for producing N-alkenyl amides |
| 04/16/2003 | CN1105706C Cyclic amidino agents useful as nitric oxide synthase inhibitors |
| 04/15/2003 | US6548665 Asymmetric synthesis of a key intermediate for making benazepril and analogues thereof |
| 04/15/2003 | US6548493 Substituted heterocycle fused gamma-carbolines |
| 04/10/2003 | WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof |
| 04/10/2003 | US20030069418 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group |
| 04/09/2003 | EP1299357A1 Novel compounds |
| 04/09/2003 | EP1131287B1 Method for treating lactams and method for purifying a lactam |
| 04/09/2003 | EP0674623B1 Bicyclic fibrinogen antagonists |
| 04/08/2003 | US6545148 Acylation of aminocaprolactam compound with a lactone compound in presence of a weak base and an organic solvent and hydrolyis of 1,3-dioxane group |
| 04/08/2003 | US6545038 Heterocyclic metalloprotease inhibitors |
| 04/08/2003 | US6544981 Anticoagulants, cardiovascular disorders |
| 04/08/2003 | US6544978 Treating Alzheimer's disease both prophylactically and therapeutically |
| 04/03/2003 | WO2003026668A1 Ophthalmologic treatment methods using selective inos inhibitors |
| 04/03/2003 | WO2003026638A1 Neuroprotective treatment methods using selective inos inhibitors |
| 04/03/2003 | WO2002086078A3 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 04/03/2003 | WO2000038618A3 SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 04/03/2003 | US20030065171 Luminescent element material, luminescent element, ethylene derivative having n-containing 7-membered ring, and benzoazepine derivative |
| 04/03/2003 | CA2455989A1 Neuroprotective treatment methods using selective inos inhibitors |
| 04/03/2003 | CA2455910A1 Ophthalmologic treatment methods using selective inos inhibitors |
| 04/02/2003 | EP0912512B1 Sulphonamide derivatives and their use in the treatment of cns disorders |
| 04/02/2003 | EP0815078B1 Process for producing caprolactam |
| 04/02/2003 | CN1104419C Benzazepine derivatives with vasopressin agonistic activity |
| 04/02/2003 | CN1104418C Benzoheterocyclic derivatives |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 04/01/2003 | US6541466 Such as 1-(N'-(3,5-difluorophenylacetyl)-L-alaninyl)-aminodibenzosuberane; for treatment of Alzheimer's disease |
| 03/27/2003 | WO2003024927A1 Process for producing lactam |
| 03/27/2003 | WO2003024924A1 Novel compounds and compositions as cathepsin inhibitors |
| 03/27/2003 | CA2460125A1 Novel compounds and compositions as cathepsin inhibitors |